Namenda Buyers Say Product Hopping Class Action Has Legs
By Kelly Knaub · February 2, 2016, 12:05 AM EST
Drug wholesalers accusing Actavis and Merz of trying to stall the release of a generic version of the Alzheimer's treatment Namenda urged a New York federal judge Friday not to toss...
To view the full article, register now.